Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Chimeric Therapeutics Ltd. ( (AU:CHM) ) has provided an announcement.
Chimeric Therapeutics Ltd. announced a change in the director’s interest notice, specifically regarding Lesley Russell’s disposal of 2,750,000 unlisted options. This change reflects the expiry of unlisted options, leaving the director with 1,739,130 shares and no options, which may impact the company’s governance and stakeholder interests.
More about Chimeric Therapeutics Ltd.
Chimeric Therapeutics Ltd. is a company listed on the Australian Securities Exchange (ASX: CHM), involved in the biotechnology industry, focusing on the development of innovative therapies.
Technical Sentiment Signal: Sell
Current Market Cap: A$8.06M
See more insights into CHM stock on TipRanks’ Stock Analysis page.